Primary Site >> Stomach Cancer

Gene >> ARHGDIB

  • 2009
  • 2011
  • 2012
  • 2013
  • 2014
  • 2015
Ref: RhoGDI2 expression is associated with tumor growth and malignant progression of gastric cancer.
PMID: 19351766
 Ref: RhoGDI2 confers gastric cancer cells resistance against cisplatin-induced apoptosis by upregulation of Bcl-2 expression.
PMID: 21752536
Ref: PLCgamma is required for RhoGDI2-mediated cisplatin resistance in gastric cancer.
PMID: 21986528
 Ref: Proteomics-based strategy to delineate the molecular mechanisms of RhoGDI2-induced metastasis and drug resistance in gastric cancer.
PMID: 22364609
 Ref: RhoGDI2 confers resistance to 5-fluorouracil in human gastric cancer cells.
PMID: 23255931
Ref: Reduced expression of Rho GDP dissociation inhibitor 2 mRNA is associated with lymph node metastasis in gastric carcinoma.
PMID: 24137348
Ref: 14-3-3sigma attenuates RhoGDI2-induced cisplatin resistance through activation of Erk and p38 in gastric cancer cells.
PMID: 24185104
 Ref: VEGF-C mediates RhoGDI2-induced gastric cancer cell metastasis and cisplatin resistance.
PMID: 24585459
Ref: RhoGDI2 promotes epithelial-mesenchymal transition via induction of Snail in gastric cancer cells.
PMID: 24721928
Ref: RhoGDI2 is associated with HGF-mediated tumor invasion through VEGF in stomach cancer.
PMID: 25253431
 Ref: RhoGDI2 up-regulates P-glycoprotein expression via Rac1 in gastric cancer cells.
PMID: 25901126